Enochian Biosciences Inc (ENOB) has 15 open-market insider trades by 6 insiders since 2018. The most active filer is Rene Sindlev, Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Rene Sindlev | Dir10% Owner | — | 10 | $3.8M | 2023-06-26 |
| Serhat Gumrukcu | 10% Owner | — | 1 | $2.0M | 2022-05-18 |
| Anderson Wittekind William | 10% Owner | — | 1 | $1.6M | 2022-10-13 |
| Henrik Gronfeldt-Sorensen | Dir | — | 1 | $100K | 2019-01-10 |
| Carl Forest Sandler | Dir10% Owner | — | 1 | $61K | 2022-04-15 |
| Eric Jean Marie Leire | — | — | 1 | $10K | 2018-05-24 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Serhat Gumrukcu | 10% Owner | Sell | $2.0M | 2022-05-18 |
| Carl Forest Sandler | Director & 10% | Sell | $17K | 2022-03-22 |
| Carl Forest Sandler | Director & 10% Owner | Sell | $123K | 2022-02-18 |
| Rene Sindlev | Director & 10% Owner | Buy | $211K | 2019-06-04 |
| Rene Sindlev | Director & 10% Owner | Buy | $268K | 2019-06-03 |
| Rene Sindlev | Director & 10% Owner | Buy | $132K |
Companies that share insiders with ENOB, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2019-05-29 |
| Rene Sindlev | Director & 10% Owner | Buy | $239K | 2019-05-28 |
| Rene Sindlev | Director & 10% | Buy | $31K | 2019-05-24 |
| Rene Sindlev | Director & 10% | Buy | $3K | 2019-05-22 |
| Rene Sindlev | Director & 10% Owner | Buy | $115K | 2019-05-21 |
| Henrik Gronfeldt-Sorensen | Director | Buy | $100K | 2019-01-10 |
| Rene Sindlev | Director & 10% Owner | Buy | $744K | 2018-12-27 |
| Rene Sindlev | Director & 10% | Buy | $7K | 2018-05-21 |
| Eric Jean Marie Leire | — | Buy | $10K | 2018-05-16 |
| Anderson Wittekind William | 10% Owner | Sell | $1.6M | 2018-02-21 |